Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125173552 | 12517355 | 2 | F | 20160620 | 20160718 | 20160630 | 20160729 | EXP | US-GLAXOSMITHKLINE-US2016088245 | GLAXOSMITHKLINE | 65.22 | YR | F | Y | 0.00000 | 20160729 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125173552 | 12517355 | 1 | PS | BREO ELLIPTA | FLUTICASONE FUROATEVILANTEROL TRIFENATATE | 1 | Respiratory (inhalation) | 1 PUFF(S), QD | R765581 | 204275 | 1 | DF | INHALATION POWDER | QD | |||||
| 125173552 | 12517355 | 2 | SS | PROAIR HFA | ALBUTEROL SULFATE | 1 | Respiratory (inhalation) | 3-4 TIMES PER DAY | UNKNOWN | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125173552 | 12517355 | 1 | Asthma |
| 125173552 | 12517355 | 2 | Asthma |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125173552 | 12517355 | Dysphemia | |
| 125173552 | 12517355 | Dysphonia | |
| 125173552 | 12517355 | Dyspnoea | |
| 125173552 | 12517355 | Wheezing |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125173552 | 12517355 | 1 | 20160606 | 0 |